HEADER TRANSFERASE 12-NOV-09 3KN5 TITLE CRYSTAL STRUCTURE OF THE C-TERMINAL KINASE DOMAIN OF MSK1 IN COMPLEX TITLE 2 WITH AMP-PNP COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBOSOMAL PROTEIN S6 KINASE ALPHA-5; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 414-738; COMPND 5 SYNONYM: NUCLEAR MITOGEN- AND STRESS-ACTIVATED PROTEIN KINASE 1, 90 COMPND 6 KDA RIBOSOMAL PROTEIN S6 KINASE 5, RSK-LIKE PROTEIN KINASE, RSKL; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MSK1, RPS6KA5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODON PLUS (DE3)-RILP; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS KINASE, AMP-PNP, MSK1, MSK, ATP-BINDING, METAL-BINDING, NUCLEOTIDE- KEYWDS 2 BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR I.D'ANGELO,M.MALAKHOVA,Z.DONG REVDAT 4 06-SEP-23 3KN5 1 REMARK REVDAT 3 09-JUN-10 3KN5 1 JRNL REVDAT 2 12-MAY-10 3KN5 1 JRNL REVDAT 1 21-APR-10 3KN5 0 JRNL AUTH M.MALAKHOVA,I.D'ANGELO,H.G.KIM,I.KURINOV,A.M.BODE,Z.DONG JRNL TITL THE CRYSTAL STRUCTURE OF THE ACTIVE FORM OF THE C-TERMINAL JRNL TITL 2 KINASE DOMAIN OF MITOGEN- AND STRESS-ACTIVATED PROTEIN JRNL TITL 3 KINASE 1. JRNL REF J.MOL.BIOL. V. 399 41 2010 JRNL REFN ISSN 0022-2836 JRNL PMID 20382163 JRNL DOI 10.1016/J.JMB.2010.03.064 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.24 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 23120 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1205 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.2453 - 4.9819 0.56 2899 148 0.2189 0.2687 REMARK 3 2 4.9819 - 3.9551 0.54 2757 144 0.1632 0.2312 REMARK 3 3 3.9551 - 3.4554 0.53 2744 138 0.1827 0.2634 REMARK 3 4 3.4554 - 3.1396 0.53 2719 147 0.2090 0.2809 REMARK 3 5 3.1396 - 2.9146 0.52 2619 159 0.2346 0.3623 REMARK 3 6 2.9146 - 2.7428 0.49 2495 130 0.2475 0.3243 REMARK 3 7 2.7428 - 2.6055 0.46 2325 140 0.2519 0.2833 REMARK 3 8 2.6055 - 2.4921 0.41 2116 107 0.2674 0.3434 REMARK 3 9 2.4921 - 2.3960 0.32 1625 92 0.2756 0.3430 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 56.09 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 63.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -13.98100 REMARK 3 B22 (A**2) : 1.31400 REMARK 3 B33 (A**2) : 12.66700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4720 REMARK 3 ANGLE : 1.104 6350 REMARK 3 CHIRALITY : 0.075 691 REMARK 3 PLANARITY : 0.003 793 REMARK 3 DIHEDRAL : 20.402 1762 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3KN5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000056199. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI(311) REMARK 200 OPTICS : MIRROR, MICROFOCUS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23504 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.396 REMARK 200 RESOLUTION RANGE LOW (A) : 43.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.11800 REMARK 200 R SYM (I) : 0.11800 REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.49200 REMARK 200 R SYM FOR SHELL (I) : 0.49200 REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2QR8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5, VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.78050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.73000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.62500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.73000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.78050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.62500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 414 REMARK 465 GLU A 555 REMARK 465 ASN A 556 REMARK 465 ASP A 557 REMARK 465 ASN A 558 REMARK 465 ASP A 575 REMARK 465 ASN A 576 REMARK 465 GLN A 577 REMARK 465 PRO A 578 REMARK 465 LEU A 579 REMARK 465 LYS A 580 REMARK 465 THR A 581 REMARK 465 PRO A 582 REMARK 465 CYS A 583 REMARK 465 PHE A 584 REMARK 465 THR A 585 REMARK 465 LEU A 586 REMARK 465 HIS A 587 REMARK 465 TYR A 588 REMARK 465 ALA A 589 REMARK 465 ALA A 590 REMARK 465 PRO A 591 REMARK 465 GLU A 592 REMARK 465 LEU A 593 REMARK 465 LEU A 594 REMARK 465 ASN A 595 REMARK 465 GLN A 596 REMARK 465 SER A 624 REMARK 465 HIS A 625 REMARK 465 ASP A 626 REMARK 465 ARG A 627 REMARK 465 SER A 628 REMARK 465 LEU A 629 REMARK 465 THR A 630 REMARK 465 PHE A 730 REMARK 465 CYS A 731 REMARK 465 LEU A 732 REMARK 465 GLN A 733 REMARK 465 ASN A 734 REMARK 465 VAL A 735 REMARK 465 ASP A 736 REMARK 465 LYS A 737 REMARK 465 ALA A 738 REMARK 465 MET B 414 REMARK 465 GLU B 555 REMARK 465 ASN B 556 REMARK 465 ASP B 557 REMARK 465 ASN B 558 REMARK 465 ASP B 575 REMARK 465 ASN B 576 REMARK 465 GLN B 577 REMARK 465 PRO B 578 REMARK 465 LEU B 579 REMARK 465 LYS B 580 REMARK 465 THR B 581 REMARK 465 PRO B 582 REMARK 465 CYS B 583 REMARK 465 PHE B 584 REMARK 465 THR B 585 REMARK 465 LEU B 586 REMARK 465 HIS B 587 REMARK 465 TYR B 588 REMARK 465 ALA B 589 REMARK 465 ALA B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 LEU B 593 REMARK 465 LEU B 594 REMARK 465 ASN B 595 REMARK 465 GLN B 596 REMARK 465 PHE B 730 REMARK 465 CYS B 731 REMARK 465 LEU B 732 REMARK 465 GLN B 733 REMARK 465 ASN B 734 REMARK 465 VAL B 735 REMARK 465 ASP B 736 REMARK 465 LYS B 737 REMARK 465 ALA B 738 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL B 610 O HOH B 84 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 426 78.43 -108.47 REMARK 500 ASN A 449 13.95 59.33 REMARK 500 ASP A 544 40.64 -152.10 REMARK 500 ASP A 565 86.51 65.89 REMARK 500 TYR A 599 95.33 -66.09 REMARK 500 SER A 633 135.38 154.87 REMARK 500 PHE A 648 58.21 -115.18 REMARK 500 ASP A 671 102.91 -34.06 REMARK 500 SER A 707 82.59 146.01 REMARK 500 GLU A 728 -53.34 167.48 REMARK 500 GLU B 434 -157.07 -134.42 REMARK 500 GLU B 476 131.48 -39.45 REMARK 500 ASP B 544 45.91 -151.14 REMARK 500 ASP B 565 80.37 61.12 REMARK 500 ALA B 569 157.46 -49.36 REMARK 500 TYR B 599 90.68 -67.67 REMARK 500 SER B 628 -178.94 92.51 REMARK 500 LEU B 629 -73.36 72.72 REMARK 500 ASP B 645 73.33 -100.62 REMARK 500 ASP B 671 -118.03 -116.47 REMARK 500 ASN B 673 89.95 163.36 REMARK 500 LYS B 674 -86.16 70.79 REMARK 500 SER B 707 34.27 -163.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANP A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANP B 400 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3KN6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE C-TERMINAL KINASE DOMAIN OF MSK1 DBREF 3KN5 A 414 738 UNP O75582 KS6A5_HUMAN 414 738 DBREF 3KN5 B 414 738 UNP O75582 KS6A5_HUMAN 414 738 SEQRES 1 A 325 MET LYS ASP SER PRO PHE TYR GLN HIS TYR ASP LEU ASP SEQRES 2 A 325 LEU LYS ASP LYS PRO LEU GLY GLU GLY SER PHE SER ILE SEQRES 3 A 325 CYS ARG LYS CYS VAL HIS LYS LYS SER ASN GLN ALA PHE SEQRES 4 A 325 ALA VAL LYS ILE ILE SER LYS ARG MET GLU ALA ASN THR SEQRES 5 A 325 GLN LYS GLU ILE THR ALA LEU LYS LEU CYS GLU GLY HIS SEQRES 6 A 325 PRO ASN ILE VAL LYS LEU HIS GLU VAL PHE HIS ASP GLN SEQRES 7 A 325 LEU HIS THR PHE LEU VAL MET GLU LEU LEU ASN GLY GLY SEQRES 8 A 325 GLU LEU PHE GLU ARG ILE LYS LYS LYS LYS HIS PHE SER SEQRES 9 A 325 GLU THR GLU ALA SER TYR ILE MET ARG LYS LEU VAL SER SEQRES 10 A 325 ALA VAL SER HIS MET HIS ASP VAL GLY VAL VAL HIS ARG SEQRES 11 A 325 ASP LEU LYS PRO GLU ASN LEU LEU PHE THR ASP GLU ASN SEQRES 12 A 325 ASP ASN LEU GLU ILE LYS ILE ILE ASP PHE GLY PHE ALA SEQRES 13 A 325 ARG LEU LYS PRO PRO ASP ASN GLN PRO LEU LYS THR PRO SEQRES 14 A 325 CYS PHE THR LEU HIS TYR ALA ALA PRO GLU LEU LEU ASN SEQRES 15 A 325 GLN ASN GLY TYR ASP GLU SER CYS ASP LEU TRP SER LEU SEQRES 16 A 325 GLY VAL ILE LEU TYR THR MET LEU SER GLY GLN VAL PRO SEQRES 17 A 325 PHE GLN SER HIS ASP ARG SER LEU THR CYS THR SER ALA SEQRES 18 A 325 VAL GLU ILE MET LYS LYS ILE LYS LYS GLY ASP PHE SER SEQRES 19 A 325 PHE GLU GLY GLU ALA TRP LYS ASN VAL SER GLN GLU ALA SEQRES 20 A 325 LYS ASP LEU ILE GLN GLY LEU LEU THR VAL ASP PRO ASN SEQRES 21 A 325 LYS ARG LEU LYS MET SER GLY LEU ARG TYR ASN GLU TRP SEQRES 22 A 325 LEU GLN ASP GLY SER GLN LEU SER SER ASN PRO LEU MET SEQRES 23 A 325 THR PRO ASP ILE LEU GLY SER SER GLY ALA ALA VAL HIS SEQRES 24 A 325 THR CYS VAL LYS ALA THR PHE HIS ALA PHE ASN LYS TYR SEQRES 25 A 325 LYS ARG GLU GLY PHE CYS LEU GLN ASN VAL ASP LYS ALA SEQRES 1 B 325 MET LYS ASP SER PRO PHE TYR GLN HIS TYR ASP LEU ASP SEQRES 2 B 325 LEU LYS ASP LYS PRO LEU GLY GLU GLY SER PHE SER ILE SEQRES 3 B 325 CYS ARG LYS CYS VAL HIS LYS LYS SER ASN GLN ALA PHE SEQRES 4 B 325 ALA VAL LYS ILE ILE SER LYS ARG MET GLU ALA ASN THR SEQRES 5 B 325 GLN LYS GLU ILE THR ALA LEU LYS LEU CYS GLU GLY HIS SEQRES 6 B 325 PRO ASN ILE VAL LYS LEU HIS GLU VAL PHE HIS ASP GLN SEQRES 7 B 325 LEU HIS THR PHE LEU VAL MET GLU LEU LEU ASN GLY GLY SEQRES 8 B 325 GLU LEU PHE GLU ARG ILE LYS LYS LYS LYS HIS PHE SER SEQRES 9 B 325 GLU THR GLU ALA SER TYR ILE MET ARG LYS LEU VAL SER SEQRES 10 B 325 ALA VAL SER HIS MET HIS ASP VAL GLY VAL VAL HIS ARG SEQRES 11 B 325 ASP LEU LYS PRO GLU ASN LEU LEU PHE THR ASP GLU ASN SEQRES 12 B 325 ASP ASN LEU GLU ILE LYS ILE ILE ASP PHE GLY PHE ALA SEQRES 13 B 325 ARG LEU LYS PRO PRO ASP ASN GLN PRO LEU LYS THR PRO SEQRES 14 B 325 CYS PHE THR LEU HIS TYR ALA ALA PRO GLU LEU LEU ASN SEQRES 15 B 325 GLN ASN GLY TYR ASP GLU SER CYS ASP LEU TRP SER LEU SEQRES 16 B 325 GLY VAL ILE LEU TYR THR MET LEU SER GLY GLN VAL PRO SEQRES 17 B 325 PHE GLN SER HIS ASP ARG SER LEU THR CYS THR SER ALA SEQRES 18 B 325 VAL GLU ILE MET LYS LYS ILE LYS LYS GLY ASP PHE SER SEQRES 19 B 325 PHE GLU GLY GLU ALA TRP LYS ASN VAL SER GLN GLU ALA SEQRES 20 B 325 LYS ASP LEU ILE GLN GLY LEU LEU THR VAL ASP PRO ASN SEQRES 21 B 325 LYS ARG LEU LYS MET SER GLY LEU ARG TYR ASN GLU TRP SEQRES 22 B 325 LEU GLN ASP GLY SER GLN LEU SER SER ASN PRO LEU MET SEQRES 23 B 325 THR PRO ASP ILE LEU GLY SER SER GLY ALA ALA VAL HIS SEQRES 24 B 325 THR CYS VAL LYS ALA THR PHE HIS ALA PHE ASN LYS TYR SEQRES 25 B 325 LYS ARG GLU GLY PHE CYS LEU GLN ASN VAL ASP LYS ALA HET ANP A 400 31 HET ANP B 400 31 HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER FORMUL 3 ANP 2(C10 H17 N6 O12 P3) FORMUL 5 HOH *84(H2 O) HELIX 1 1 MET A 461 CYS A 475 1 15 HELIX 2 2 GLU A 505 LYS A 513 1 9 HELIX 3 3 SER A 517 VAL A 538 1 22 HELIX 4 4 LYS A 546 GLU A 548 5 3 HELIX 5 5 ASP A 600 GLY A 618 1 19 HELIX 6 6 SER A 633 GLY A 644 1 12 HELIX 7 7 GLY A 650 ASN A 655 1 6 HELIX 8 8 SER A 657 THR A 669 1 13 HELIX 9 9 ASN A 684 GLN A 688 5 5 HELIX 10 10 MET A 699 SER A 706 1 8 HELIX 11 11 SER A 707 ARG A 727 1 21 HELIX 12 12 SER B 417 HIS B 422 1 6 HELIX 13 13 MET B 461 CYS B 475 1 15 HELIX 14 14 GLU B 505 LYS B 512 1 8 HELIX 15 15 SER B 517 VAL B 538 1 22 HELIX 16 16 LYS B 546 GLU B 548 5 3 HELIX 17 17 GLU B 601 GLY B 618 1 18 HELIX 18 18 SER B 633 GLY B 644 1 12 HELIX 19 19 SER B 657 THR B 669 1 13 HELIX 20 20 LYS B 677 ARG B 682 1 6 HELIX 21 21 TYR B 683 GLN B 688 5 6 HELIX 22 22 MET B 699 GLU B 728 1 30 SHEET 1 A 3 TYR A 423 LEU A 425 0 SHEET 2 A 3 SER A 438 HIS A 445 -1 O VAL A 444 N ASP A 424 SHEET 3 A 3 GLY A 433 GLY A 435 -1 N GLY A 433 O CYS A 440 SHEET 1 B 5 TYR A 423 LEU A 425 0 SHEET 2 B 5 SER A 438 HIS A 445 -1 O VAL A 444 N ASP A 424 SHEET 3 B 5 ALA A 451 SER A 458 -1 O PHE A 452 N CYS A 443 SHEET 4 B 5 HIS A 493 GLU A 499 -1 O THR A 494 N ILE A 457 SHEET 5 B 5 LEU A 484 HIS A 489 -1 N PHE A 488 O PHE A 495 SHEET 1 C 2 VAL A 540 VAL A 541 0 SHEET 2 C 2 ARG A 570 LEU A 571 -1 O ARG A 570 N VAL A 541 SHEET 1 D 2 LEU A 550 PHE A 552 0 SHEET 2 D 2 ILE A 561 ILE A 563 -1 O LYS A 562 N LEU A 551 SHEET 1 E 5 TYR B 423 LEU B 425 0 SHEET 2 E 5 SER B 438 HIS B 445 -1 O VAL B 444 N ASP B 424 SHEET 3 E 5 GLN B 450 SER B 458 -1 O VAL B 454 N ARG B 441 SHEET 4 E 5 HIS B 493 GLU B 499 -1 O MET B 498 N ALA B 453 SHEET 5 E 5 LEU B 484 HIS B 489 -1 N PHE B 488 O PHE B 495 SHEET 1 F 2 VAL B 540 VAL B 541 0 SHEET 2 F 2 ARG B 570 LEU B 571 -1 O ARG B 570 N VAL B 541 SHEET 1 G 2 LEU B 550 PHE B 552 0 SHEET 2 G 2 ILE B 561 ILE B 563 -1 O LYS B 562 N LEU B 551 SSBOND 1 CYS A 631 CYS A 714 1555 1555 2.05 SSBOND 2 CYS B 631 CYS B 714 1555 1555 2.06 CISPEP 1 SER A 679 GLY A 680 0 5.22 CISPEP 2 ARG A 727 GLU A 728 0 -13.67 CISPEP 3 GLU A 728 GLY A 729 0 -1.51 CISPEP 4 VAL B 670 ASP B 671 0 -7.86 CISPEP 5 ASP B 671 PRO B 672 0 0.56 CISPEP 6 ASN B 673 LYS B 674 0 -14.92 CISPEP 7 GLU B 728 GLY B 729 0 -2.02 SITE 1 AC1 13 HOH A 66 LEU A 432 GLY A 433 GLU A 434 SITE 2 AC1 13 GLU A 499 LEU A 500 LEU A 501 GLU A 505 SITE 3 AC1 13 GLU A 548 LEU A 551 ILE A 564 LYS A 643 SITE 4 AC1 13 LYS A 716 SITE 1 AC2 11 HOH B 76 LEU B 432 GLY B 433 GLU B 434 SITE 2 AC2 11 GLU B 499 LEU B 500 LEU B 501 GLU B 505 SITE 3 AC2 11 GLU B 548 LEU B 551 ILE B 564 CRYST1 51.561 91.250 135.460 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019395 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010959 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007382 0.00000